150 related articles for article (PubMed ID: 31380833)
1. Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells.
Di Cocco S; Belloni L; Nunn ADG; Salerno D; Piconese S; Levrero M; Pediconi N
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31380833
[TBL] [Abstract][Full Text] [Related]
2. Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model.
Belloni L; Di Cocco S; Guerrieri F; Nunn ADG; Piconese S; Salerno D; Testoni B; Pulito C; Mori F; Pallocca M; Sacconi A; Vivoli E; Marra F; Strano S; Blandino G; Levrero M; Pediconi N
Sci Rep; 2018 Sep; 8(1):13638. PubMed ID: 30206377
[TBL] [Abstract][Full Text] [Related]
3. Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy.
Le TT; Ziemba A; Urasaki Y; Brotman S; Pizzorno G
PLoS One; 2012; 7(11):e51092. PubMed ID: 23226469
[TBL] [Abstract][Full Text] [Related]
4. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells.
Tanner N; Kubik L; Luckert C; Thomas M; Hofmann U; Zanger UM; Böhmert L; Lampen A; Braeuning A
Drug Metab Dispos; 2018 Apr; 46(4):326-335. PubMed ID: 29330220
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
7. Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells.
Anthérieu S; Rogue A; Fromenty B; Guillouzo A; Robin MA
Hepatology; 2011 Jun; 53(6):1895-905. PubMed ID: 21391224
[TBL] [Abstract][Full Text] [Related]
8. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
9. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
[TBL] [Abstract][Full Text] [Related]
10. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.
Kirovski G; Gäbele E; Dorn C; Moleda L; Niessen C; Weiss TS; Wobser H; Schacherer D; Buechler C; Wasmuth HE; Hellerbrand C
Int J Clin Exp Pathol; 2010 Aug; 3(7):675-80. PubMed ID: 20830238
[TBL] [Abstract][Full Text] [Related]
12. High-fat diet overfeeding promotes nondetrimental liver steatosis in female mice.
Arisqueta L; Navarro-Imaz H; Labiano I; Rueda Y; Fresnedo O
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G772-G780. PubMed ID: 30095299
[TBL] [Abstract][Full Text] [Related]
13. [Tumor suppressor gene PTEN and non-alcoholic steatohepatitis (NASH)].
Sato W; Horie Y; Watanabe S; Suzuki A
Nihon Rinsho; 2005 Aug; 63(8):1475-83. PubMed ID: 16101243
[TBL] [Abstract][Full Text] [Related]
14. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
15. A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium.
Campos-Espinosa A; Guzmán C
J Vis Exp; 2021 May; (171):. PubMed ID: 34096925
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL; Peng XE; Zhu YB; Yan XL; Chen WN; Lin X
J Virol; 2016 Feb; 90(4):1729-40. PubMed ID: 26637457
[TBL] [Abstract][Full Text] [Related]
17. Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes.
De Gottardi A; Vinciguerra M; Sgroi A; Moukil M; Ravier-Dall'Antonia F; Pazienza V; Pugnale P; Foti M; Hadengue A
Lab Invest; 2007 Aug; 87(8):792-806. PubMed ID: 17558421
[TBL] [Abstract][Full Text] [Related]
18. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
19. Perilipin discerns chronic from acute hepatocellular steatosis.
Pawella LM; Hashani M; Eiteneuer E; Renner M; Bartenschlager R; Schirmacher P; Straub BK
J Hepatol; 2014 Mar; 60(3):633-42. PubMed ID: 24269473
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of intrahepatic triglyceride accumulation.
Ress C; Kaser S
World J Gastroenterol; 2016 Jan; 22(4):1664-73. PubMed ID: 26819531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
